Pediatrix Medical Group (NYSE:MD) Stock Rating Upgraded by Wall Street Zen

Pediatrix Medical Group (NYSE:MD) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Sunday, Wall Street Zen reports.

Other equities analysts have also issued reports about the company. UBS Group increased their price target on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $25.00 price objective on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Weiss Ratings raised Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, September 9th. Truist Financial lifted their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. Finally, Jefferies Financial Group cut shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and boosted their price target for the stock from $27.00 to $28.00 in a research report on Wednesday, August 19th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $26.60.

Pediatrix Medical Group Stock Up 0.5%

Pediatrix Medical Group stock opened at $26.91 on Friday. The stock has a market cap of $2.19 billion, a price-to-earnings ratio of 12.88 and a beta of 0.64. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45. The company’s 50-day moving average price is $26.41 and its two-hundred day moving average price is $23.66. Pediatrix Medical Group has a 52 week low of $15.69 and a 52 week high of $27.94.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.59 by $0.04. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The company had revenue of $487.78 million during the quarter, compared to analyst estimates of $478.49 million. During the same period in the prior year, the business posted $0.53 EPS. The business’s revenue for the quarter was up 4.1% compared to the same quarter last year. On average, analysts expect that Pediatrix Medical Group will post 2.17 EPS for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Several hedge funds have recently modified their holdings of the stock. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Pediatrix Medical Group during the fourth quarter worth approximately $33,000. Global Retirement Partners LLC purchased a new position in Pediatrix Medical Group during the second quarter valued at approximately $33,000. Nykredit A S acquired a new position in Pediatrix Medical Group in the 2nd quarter valued at approximately $35,000. TD Private Client Wealth LLC acquired a new position in Pediatrix Medical Group in the 4th quarter valued at approximately $39,000. Finally, Integrated Wealth Concepts LLC purchased a new stake in Pediatrix Medical Group in the 2nd quarter worth approximately $53,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc is a physician-led healthcare services company that provides specialized medical care for women, infants and children. The company partners with hospitals and health systems to deliver care through physician practices, neonatal intensive care units and other hospital-based programs.

Its services include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric hospital medicine and other pediatric subspecialties. Pediatrix physicians care for patients before, during and after childbirth, as well as children requiring specialized or critical care.